Tetsuo Nishikawa


Affiliation: Tohoku Rosai Hospital
Country: Japan


  1. Nishikawa T, Omura M, Saito J, Matsuzawa Y. Primary aldosteronism: comparison between guidelines of the Japanese and the US Endocrine Society. Expert Rev Endocrinol Metab. 2012;7:637-645 pubmed publisher
    ..Laterality of PA should be precisely evaluated with AVS and imaging studies, as the results strongly influence the choice of therapeutic strategies. ..
  2. Matsuzawa Y, Suematsu S, Saito J, Omura M, Nishikawa T. Vascular aldosterone production at the pre-diabetic stage of young Otsuka Long-Evans Tokushima Fatty (OLETF) rats, compared with Long-Evans Tokushima Otsuka (LETO) rats. Molecules. 2013;18:15636-47 pubmed publisher
  3. request reprint
    Nishikawa T, Suematsu S, Saito J, Soyama A, Ito H, Kino T, et al. Human renal mesangial cells produce aldosterone in response to low-density lipoprotein (LDL). J Steroid Biochem Mol Biol. 2005;96:309-16 pubmed
  4. Nishikawa T, Matsuzawa Y, Suematsu S, Saito J, Omura M, Kino T. Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells. Arzneimittelforschung. 2010;60:445-51 pubmed publisher
  5. request reprint
    Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J. 2011;58:711-21 pubmed
    ..In contrast, patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, are optimally treated medically with mineralocorticoid receptor antagonists. ..
  6. Tamura A, Nishimoto K, Seki T, Matsuzawa Y, Saito J, Omura M, et al. Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism. Mol Cell Endocrinol. 2017;441:134-139 pubmed publisher